In sepsis, a tailored precision immunotherapy strategy improved organ function at 9 d

Key Points

• To evaluate the effectiveness of a precision immunotherapy strategy in improving organ function in patients with sepsis.
• Implemented a tailored immunotherapy protocol based on individual patient profiles.
• Assessed organ function levels at baseline and after 9 days of treatment.
• Monitored outcomes across multiple critical care departments.
• Significant improvement in organ function observed at day 9 after treatment.
• Demonstrated strong correlation between tailored immunotherapy and enhanced clinical outcomes.
• No adverse effects reported, suggesting safety of the approach.

Abstract